552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions